Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia

Long-term application of Tamoxifen (TAM) is usually recommended for hormone receptor positive breast cancer patients. Unfortunately, TAM will inevitably increase the incidence of endometrial hyperplasia even endometrial cancer. Despite of substantial investigations, no effective approaches to preven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Feng, Lifeng, Li, Jiaqiu, Yang, Lixian, Zhu, Libo, Huang, Xiufeng, Zhang, Shuzheng, Luo, Likang, Jiang, Zhinong, Jiang, Tingting, Xu, Wenxia, Wang, Xian, Jin, Hongchuan
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5479276/
https://ncbi.nlm.nih.gov/pubmed/28638475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.19135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados